BioNote, Inc. (KRX:377740)

BioNote Revenue

BioNote had revenue of 36.37B KRW in the quarter ending June 30, 2026, with 12.23% growth. This brings the company's total for the last twelve months to 126.41B, up 12.82% year-over-year. In the year 2025, BioNote had annual revenue of 118.32B with 15.12% growth. That makes BioNote the 23,020th largest company in the world by revenue and 1,296th in South Korea.

• Revenue (ttm): 126.41B
• Revenue Growth: +12.82%
• P/S Ratio: 3.66
• Revenue / Employee: 422.76M
• Employees: 299
• Market Cap: 463.19B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Animal 81.76B 69.1%
• Life Science 36.57B 30.9%

By Geography

Chart

• Overseas 82.25B 69.5%
• South Korea 36.07B 30.5%

Fiscal year ended Dec 31, 2025 See the full BioNote breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	118.32B	15.54B	15.12%
Dec 31, 2024	102.78B	12.70B	14.10%
Dec 31, 2023	90.08B	-389.58B	-81.22%
Dec 31, 2022	479.66B	-142.70B	-22.93%
Dec 31, 2021	622.36B	-9.15B	-1.45%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error